Compared to the placebo, patients treated with Kisunla had a 35% slower cognitive and functional decline at 18 months of ...

Lilly's success doesn't depend entirely on its obesity drug, though. Mounjaro, which is approved for type 2 diabetes, is the same drug under the hood as Zepbound and also has tremendous commercial ...

Alzheimer’s drug, donanemab (marketed as Kisunla), could be rejected for use by the National Health Service (NHS) in Britain, ...

Shortly after a U.K. watchdog declined to endorse Biogen's ( NASDAQ: BIIB) Alzheimer's drug Leqembi for use in the country's ...

Several large-cap stocks have a big head start that could enable them to finish the year strong. I predict these will be the ...

Doctors said the drug Kisunla is the first drug to be approved by the FDA for Alzheimer’s in more than a decade giving hope ...

A multidisciplinary team of scientists led by Kurt Brunden, Ph.D., at the Perelman School of Medicine, and Carlo Ballatore, Ph.D., at University of California San Diego, has been awarded a $6.9 ...

The FDA approved donanemab last month as Kisunla. The members of Congress also pointed to Pfizer’s Inlyta (axitinib), for ...

Several people in fresno were among the first in the nation to receive a new treatment for alzheimer's disease.Now patients ...

As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is ...

A multidisciplinary team of scientists led by Carlo Ballatore, Ph.D., at University of California San Diego and Kurt Brunden, Ph.D., at the University of Pennsylvania has been awarded a $6.9 million ...

FRESNO, Calif. (KFSN) -- A long-time Fresno doctor is part of a ground-breaking treatment in the fight against Alzheimer's.